 |
|
HER-2/neu Oncogene Characterization in Head and Neck Squamous Cell Carcinoma
Russell N. Beckhardt, MD;
Nobutaka Kiyokawa, MD, PhD;
Lei Xi, PhD;
Ta-Jen Liu, PhD;
Mien-Chie Hung, PhD;
Adel K. El-Naggar, MD, PhD;
Hua-Zhong Zhang, MD;
Gary L. Clayman, DDS, MD
Arch Otolaryngol Head Neck Surg. 1995;121(11):1265-1270.
Abstract
| |
Objective
To characterize the HER-2/neu oncogene in head and neck squamous cell carcinoma (HNSCC) cell lines and tumor tissue specimens.
Design
Molecular analysis of HER-2/neu oncogene amplification and expression in HNSCC cell lines by Southern, Northern, and Western blot techniques, and HER-2/neu oncoprotein expression in HNSCC tumor tissue sections by immunohistochemical analysis.
Specimens
Eleven HNSCC cell lines, eight paired samples of frozen HNSCC tumor tissue specimens and adjacent nonmalignant mucosa, and 38 paraffinembedded slides derived from HNSCC tumor specimens (including those from which the cell lines were derived) were analyzed.
Results
Southern blot analysis showed twofold HER-2/neu gene amplification in two (18%) of the 11 HNSCC cell lines, MDA-1386 and Tu-167. Northern blot analysis showed messenger RNA overexpression in the same two cell lines, and to a lesser degree in MDA-1483. Western blot analysis showed high levels of HER-2/neu oncoprotein expression in two (18%) of the 11 cell lines (MDA-1386 and Tu-167), a moderate level of protein expression in one cell line (9%) (MDA-1483), and low levels of protein expression in eight cell lines (73%) Some HER-2/neu protein expression was seen in all of the HNSCC cell lines. Immunohistochemical analysis of the tumor tissue sections from which the cell lines were derived corroborated the Western blot results. Western blot analysis of frozen primary tumor specimens showed HER-2/neu oncoprotein overexpression in two (25%) of eight specimens. Immunohistochemical analysis showed high levels of protein expression in six (16%) of the 38 tumor tissue slides, moderate levels in 12 (31%), and low levels in 20 (53%).
Conclusions
The HER-2/neu oncogene is overexpressed in a subset of HNSCC tumors and cell lines. The results from Western blot and immunohistochemical analyses underscore a variable HER2/neu oncoprotein expression in HNSCC. Gene amplification was observed in a few of the cell lines, suggesting a potential mechanism of oncoprotein overexpression. Messenger RNA overexpression, however, can be seen in the absence of gene amplification, indicating that transcriptional or posttranscriptional control mechanisms must be involved. Further studies are indicated to determine the biologic role of HER-2/neu expression in the clinical progression of these lesions and to further define the molecular basis regulating its expression.
(Arch Otolaryngol Head Neck Surg. 1995;121:1265-1270)
Author Affiliations
From the Departments of Head and Neck Surgery (Drs Beckhardt, Liu, and Clayman), Tumor Biology (Drs Kiyokawa, Xi, and Hung), and Pathology (Drs El-Naggar and Zhang), The University of Texas M. D. Anderson Cancer Center, Houston.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
Gravalos and Jimeno
Ann Oncol 2008;19:1523-1529.
ABSTRACT
| FULL TEXT
Insulin-like Growth Factor Receptor as a Therapeutic Target in Head and Neck Cancer
Barnes et al.
Clin. Cancer Res. 2007;13:4291-4299.
ABSTRACT
| FULL TEXT
Identification of Angiogenesis/Metastases Genes Predicting Chemoradiotherapy Response in Patients With Laryngopharyngeal Carcinoma
Ganly et al.
JCO 2007;25:1369-1376.
ABSTRACT
| FULL TEXT
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth
Leong et al.
Proc. Natl. Acad. Sci. USA 2003;100:4138-4143.
ABSTRACT
| FULL TEXT
ErbB-2 Activates Stat3alpha in a Src- and JAK2-dependent Manner
Ren and Schaefer
J. Biol. Chem. 2002;277:38486-38493.
ABSTRACT
| FULL TEXT
Targeted Molecular Therapy for Oral Cancer With Epidermal Growth Factor Receptor Blockade: A Preliminary Report
Myers et al.
Arch Otolaryngol Head Neck Surg 2002;128:875-879.
ABSTRACT
| FULL TEXT
Polysomies of Chromosomes 7 and 17 in Head and Neck Squamous Cell Carcinomas
Choi and Chung
Arch Otolaryngol Head Neck Surg 1996;122:1062-1067.
ABSTRACT
|
